Article
Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
Pathology international - 1 Jun 2014
Guo Ying, Arakawa Fumiko, Miyoshi Hiroaki, Niino Daisuke, Kawano Riko, Ohshima Koichi
Abstract excerpt
Janus Kinase 3 (JAK3) is a non-receptor tyrosine kinase, predominantly expressed in hematopoietic cells, that plays an essential role in hematopoiesis during T cell development. JAK3 somatic-activating mutations were identified in extranodal natural killer/T cell lymphomas (ENKTL) in recent cases in Singapore. We hypothesized these mutations might play an important role in the pathogenesis of T and NK cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
